Skip to search formSkip to main contentSkip to account menu

3-hydroxymethylphenytoin valproic acid ester

Known as: VAL-PHT 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
As survival and outcomes continue to improve in neonates born prematurely, there is an increasing need to promptly identify and… 
Highly Cited
2013
Highly Cited
2013
Our ability to project the impact of global change on marine ecosystem is limited by our poor understanding on how to predict… 
Highly Cited
2010
Highly Cited
2010
Rho-kinase (ROCK) inhibitors prevent pulmonary hypertension (PHT) in adult rodents, but little is known about their effects on… 
Highly Cited
2008
Highly Cited
2008
Purpose:  Previous studies found a strong association between HLA‐B*1502 and carbamazepine (CBZ)‐induced Stevens‐Johnson syndrome… 
Highly Cited
2006
Highly Cited
2006
The dual endothelin receptor antagonist, bosentan, and the phosphodiesterase inhibitor, sildenafil, are efficacious in… 
Highly Cited
2002
Highly Cited
2002
Endothelin-1 (ET-1) mediates the development of pulmonary hypertension (PHT) in newborn rats exposed to 60% O(2) for 14 days, a… 
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To evaluate postexposure prophylaxis (PEP) in dogs experimentally infected with rabies. ANIMALS 29 Beagles… 
Highly Cited
1999
Highly Cited
1999
Background: Prevention of variceal bleeding, a major cause of morbidity and mortality, is an important goal in the management of… 
Highly Cited
1987
Highly Cited
1987
Portal hypertension (PHT) is known to be associated with a hyperdynamic circulation, yet the pathogenesis of both remains unclear…